Resonance Specialties Limited (BOM:524218)

Market Cap	1.14B +12.3%
Revenue (ttm)	899.72M +28.6%
Net Income	88.58M +112.0%
EPS	7.71 +113.0%
Shares Out	11.54M
PE Ratio	12.87
Forward PE	n/a
Dividend	1.00 (0.98%)
Ex-Dividend Date	n/a

Volume	3,226
Average Volume	13,505
Open	104.85
Previous Close	104.60
Day's Range	101.45 - 104.85
52-Week Range	65.00 - 124.50
Beta	-0.13
RSI	43.59
Earnings Date	Feb 4, 2026

About Resonance Specialties

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in manufacturing agrochemicals, pharmaceuticals and bulk drugs, dyes, rubber chemicals, etc.; cyanopyridines that are applied in manufacturing of niacinamide; and picolines, including alpha, beta, and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate,...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1989
• Employees: 66
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524218

Financial Performance

In fiscal year 2025, Resonance Specialties's revenue was 778.07 million, an increase of 40.70% compared to the previous year's 553.01 million. Earnings were 65.66 million, an increase of 121.20%.